{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-112267","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2025-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.053096+00:00","generated_at":"2026-05-17T09:11:33.559290+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arcadia CFO Mark Kawakami resigns; CEO Schaefer adds interim CFO role","bullets":["CFO Mark Kawakami resigns effective September 12, 2025; not due to any disagreement with the Company or auditors.","CEO Thomas J. Schaefer appointed interim CFO and principal accounting officer, effective upon Kawakami's resignation.","Schaefer previously served as CFO from January 2023 to July 2024; no compensation change for the additional role.","Schaefer will be available as an advisor after his departure; transition proceeds smoothly."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-112267","json":"https://secwatch.observer/filing/0000950170-25-112267.json","markdown":"https://secwatch.observer/filing/0000950170-25-112267.md","text":"https://secwatch.observer/filing/0000950170-25-112267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017025112267/0000950170-25-112267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017025112267/rkda-20250826.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:11:33.559290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}